Biodesix (BDSX)

Healthcare · Diagnostics & Research
$26.02 +1.52% on the day Market cap $255M 52-week range $5.26 to $31.97 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Biodesix's free cash flow was negative in fiscal 2025, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

D

Five factors scored 1 to 9 from BDSX's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation4
Profitability0
Growth9
Financial health4
Cash efficiency0

Results from SEC filings

Fiscal years, from Biodesix's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$55M$38M$49M$71M$88M
Net income-$43M-$65M-$52M-$43M-$35M
Free cash flow-$30M-$48M-$46M-$52M-$24M
EPS (diluted)-$31.60-$31.00-$12.80-$6.64-$4.67
Operating margin-75.1%-132.4%-84.2%-48.4%-31.5%

Where the revenue comes from

Revenue by products, fiscal 2025. Every breakdown, year by year.

Diagnostic Tests$79M89%
Development Services$9M11%

Superinvestors who own BDSX

From each investor's latest 13F filing (what a 13F shows).

None of the superinvestors we track held BDSX in their latest 13F.

Insider buying

Open-market purchases by Biodesix's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.

DateInsiderSharesPriceValue
Jan 26, 2026 Jack W Schuler
20,000$11.80$236,000
Jan 23, 2026 Jack W Schuler
80,000$11.81$944,800
Jan 22, 2026 Jack W Schuler
82,465$10.96$903,816

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when BDSX trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are Biodesix insiders buying the stock?

3 open-market insider purchases of BDSX in the last 12 months, from SEC Form 4 filings.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.